Literature DB >> 25118645

The burden of HPV-associated anogenital cancers.

Katie Wakeham1, Kimberley Kavanagh.   

Abstract

The epidemiology of anogenital cancers is under going substantial change. Cervical cancer remains a major public health concern, particular in resource-limited settings. Cancers of the anus, penis, vagina and vulva are relatively uncommon cancers, but may be increasing in incidence. The change in occurrence of anogenital cancers may be due to increasing HPV transmission secondary to changes in sexual behaviour. Screening programmes and the HPV vaccine offer optimism that anogenital cancers can be prevented. This article reviews the epidemiology of anogenital cancers with a focus on Scottish data.

Entities:  

Mesh:

Year:  2014        PMID: 25118645     DOI: 10.1007/s11912-014-0402-4

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.945


  94 in total

1.  Wide local excision (WLE) for vaginal intraepithelial neoplasia (VAIN).

Authors:  D Cheng; T Y Ng; H Y Ngan; L C Wong
Journal:  Acta Obstet Gynecol Scand       Date:  1999-08       Impact factor: 3.636

2.  Cohort mortality from carcinoma of the cervix.

Authors:  G B Hill; A M Adelstein
Journal:  Lancet       Date:  1967-09-16       Impact factor: 79.321

3.  Trends in vulvar neoplasia. Increasing incidence of vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva in young women.

Authors:  E A Joura; A Lösch; M G Haider-Angeler; G Breitenecker; S Leodolter
Journal:  J Reprod Med       Date:  2000-08       Impact factor: 0.142

Review 4.  HPV vaccination in boys and men.

Authors:  Margaret Stanley
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 5.  Prognostic factors in penile cancer.

Authors:  Vincenzo Ficarra; Bulent Akduman; Olivier Bouchot; Joan Palou; Marcos Tobias-Machado
Journal:  Urology       Date:  2010-08       Impact factor: 2.649

6.  Determinants of prevalence, acquisition, and persistence of human papillomavirus in healthy Mexican military men.

Authors:  Martín Lajous; Nancy Mueller; Aurelio Cruz-Valdéz; Luis Victor Aguilar; Silvia Franceschi; Mauricio Hernández-Avila; Eduardo Lazcano-Ponce
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-07       Impact factor: 4.254

7.  Malignancies that occur before and after anal cancer: clues to their etiology.

Authors:  M Frisch; J H Olsen; M Melbye
Journal:  Am J Epidemiol       Date:  1994-07-01       Impact factor: 4.897

8.  The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients.

Authors:  M P Burger; H Hollema; A G Emanuels; M Krans; E Pras; J Bouma
Journal:  Gynecol Oncol       Date:  1995-06       Impact factor: 5.482

9.  Cancer risk following organ transplantation: a nationwide cohort study in Sweden.

Authors:  J Adami; H Gäbel; B Lindelöf; K Ekström; B Rydh; B Glimelius; A Ekbom; H-O Adami; F Granath
Journal:  Br J Cancer       Date:  2003-10-06       Impact factor: 7.640

10.  Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials.

Authors:  Guglielmo Ronco; Joakim Dillner; K Miriam Elfström; Sara Tunesi; Peter J F Snijders; Marc Arbyn; Henry Kitchener; Nereo Segnan; Clare Gilham; Paolo Giorgi-Rossi; Johannes Berkhof; Julian Peto; Chris J L M Meijer
Journal:  Lancet       Date:  2013-11-03       Impact factor: 79.321

View more
  25 in total

1.  Therapeutic DNA Vaccines for Human Papillomavirus and Associated Diseases.

Authors:  Max A Cheng; Emily Farmer; Claire Huang; John Lin; Chien-Fu Hung; T-C Wu
Journal:  Hum Gene Ther       Date:  2018-03-16       Impact factor: 5.695

Review 2.  Current state in the development of candidate therapeutic HPV vaccines.

Authors:  Andrew Yang; Jessica Jeang; Kevin Cheng; Ting Cheng; Benjamin Yang; T-C Wu; Chien-Fu Hung
Journal:  Expert Rev Vaccines       Date:  2016-03-07       Impact factor: 5.217

3.  Characterization of HPV18 E6-specific T cell responses and establishment of HPV18 E6-expressing tumor model.

Authors:  Ying Ma; Andrew Yang; Shiwen Peng; Jin Qiu; Emily Farmer; Chien-Fu Hung; T-C Wu
Journal:  Vaccine       Date:  2017-06-07       Impact factor: 3.641

Review 4.  The current state of therapeutic and T cell-based vaccines against human papillomaviruses.

Authors:  Andrew Yang; Emily Farmer; John Lin; T-C Wu; Chien-Fu Hung
Journal:  Virus Res       Date:  2016-12-06       Impact factor: 3.303

Review 5.  Cervical Cancer Immunotherapy: Facts and Hopes.

Authors:  Louise Ferrall; Ken Y Lin; Richard B S Roden; Chien-Fu Hung; T-C Wu
Journal:  Clin Cancer Res       Date:  2021-04-22       Impact factor: 12.531

6.  Enhanced therapeutic efficacy of Listeria-based cancer vaccine with codon-optimized HPV16 E7.

Authors:  Feifei Duan; Jiaqi Chen; Hao Yao; Yuting Wang; Yanyan Jia; Zhiting Ling; Youwei Feng; Zhiming Pan; Yuelan Yin; Xin'An Jiao
Journal:  Hum Vaccin Immunother       Date:  2021-01-15       Impact factor: 3.452

7.  Identification of Tumor Microenvironment and DNA Methylation-Related Prognostic Signature for Predicting Clinical Outcomes and Therapeutic Responses in Cervical Cancer.

Authors:  Bangquan Liu; Jiabao Zhai; Wanyu Wang; Tianyu Liu; Chang Liu; Xiaojie Zhu; Qi Wang; Wenjing Tian; Fubin Zhang
Journal:  Front Mol Biosci       Date:  2022-04-19

Review 8.  The Human Papillomavirus E6 PDZ Binding Motif: From Life Cycle to Malignancy.

Authors:  Ketaki Ganti; Justyna Broniarczyk; Wiem Manoubi; Paola Massimi; Suruchi Mittal; David Pim; Anita Szalmas; Jayashree Thatte; Miranda Thomas; Vjekoslav Tomaić; Lawrence Banks
Journal:  Viruses       Date:  2015-07-02       Impact factor: 5.048

Review 9.  Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research.

Authors:  Sung Jong Lee; Andrew Yang; T C Wu; Chien Fu Hung
Journal:  J Gynecol Oncol       Date:  2016-05-31       Impact factor: 4.401

Review 10.  Perspectives for therapeutic HPV vaccine development.

Authors:  Andrew Yang; Emily Farmer; T C Wu; Chien-Fu Hung
Journal:  J Biomed Sci       Date:  2016-11-04       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.